Research Paper Volume 15, Issue 15 pp 7781—7793
The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)
Figure 3. Kaplan-Meier curve for time to tumor progression for gliomas with different IDH status. The PFS of patients with IDH mutation was longer than that of IDH-wild type patients.